Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Mie

Mie Abe, Watertown, MA US

Patent application numberDescriptionPublished
20100035860INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY - The invention relates to the use of protein tyrosine phosphatase inhibitors for the promotion of physiological cardiac hypertrophy and the treatment of pathological cardiac hypertrophy.02-11-2010

Mie Hara, Tokyo JP

Patent application numberDescriptionPublished
20120114594MUSCLE REPAIR PROMOTER - The present invention relates to muscle repair promoters for topical application that contain a colony-stimulating factor (CSF) as an active ingredient. The muscle repair promoters of the present invention exhibit their effect at low doses, particularly when they are administered intramuscularly.05-10-2012

Mie Ishii, Tokyo JP

Patent application numberDescriptionPublished
20090093966Hybridization data processing method using probe array - A data processing method of reducing signals to numerical values and processing the numerical values are provided. The signals are obtained by using a probe array where probes of a plurality of kinds are immobilized on a solid phase as so many spots such that a plurality of spots of probes of one kind are arranged on the solid phase and causing the array to react with a target substance. The method comprises (04-09-2009
20100121798INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, PATTERN RECOGNITION APPARATUS, AND PATTERN RECOGNITION METHOD - In a hierarchical neural network having a module structure, learning necessary for detection of a new feature class is executed by a processing module which has not finished learning yet and includes a plurality of neurons which should learn an unlearned feature class and have an undetermined receptor field structure by presenting a predetermined pattern to a data input layer. Thus, a feature class necessary for subject recognition can be learned automatically and efficiently.05-13-2010
20120044390IMAGE CAPTURING APPARATUS AND CONTROL METHOD FOR THE SAME - An image capturing apparatus includes an image sensor having an effective pixel area composed of effective pixels that photoelectrically convert an object image and a reference pixel area composed of reference pixels that output pixel signals to be a reference; a first calculation unit that calculates a standard deviation of the pixel signals output from the reference pixel area; a second calculation unit that calculates an integrated value of the pixel signals output from the reference pixel area; a third calculation unit that calculates a correction value for correcting pixel signals output from the effective pixel area, with use of the integrated value; a correction unit that corrects the pixel signals output from the effective pixel area, based on the correction value; and a determination unit that determines whether correction is to be performed by the correction unit, according to the standard deviation.02-23-2012

Patent applications by Mie Ishii, Tokyo JP

Mie Ishii, Machida-Shi JP

Patent application numberDescriptionPublished
20090011413Method for screening colon cancer cells and gene set used for examination of colon cancer - Colon cancer cells in a sample are screened by analyzing the amount of expression of at least 2 or more genes or products thereof selected from the group of genes listed in Tables 1 and 30. As compared to conventional method, patients having colon cancer can be detected with higher accuracy. Colon cancer cells in stool are also screened by analyzing expression of genes selected from the group of genes listed in Table 37.01-08-2009

Mie Larsen, Hvidovre DK

Patent application numberDescriptionPublished
20090143335MODIFIED ABSORPTION FORMULATION OF GABOXADOL - The present invention relates to a pharmaceutical composition comprising gaboxadol or a pharmaceutically acceptable salt thereof and one or more inhibitors of PAT1 and/or one or more inhibitors of OAT. The present invention further relates to a pharmaceutical composition comprising from about 0.5 mg to about 50 mg gaboxadol or a pharmaceutically acceptable salt thereof, wherein the composition provides an in vivo plasma profile comprising a mean Tmax which is longer than about 20 minutes.06-04-2009

Mie Matsuo, Kanagawa-Ken JP

Patent application numberDescriptionPublished
20100025860SEMICONDUCTOR DEVICE AND MANUFACTURING METHOD OF SEMICONDUCTOR DEVICE - In one aspect of the present invention, a semiconductor device, may include 02-04-2010

Mie Minegawa, Tokyo JP

Patent application numberDescriptionPublished
20100100031IONTOPHORESIS DEVICE - The present invention provides an iontophoresis device with high administration efficient of a drug. An iontophoresis device, including an active electrode structure including: an electrode to which a positive electrical potential is applied; a drug holding part for holding a drug solution containing positively charged drug ions, the drug holding part being placed on a front side of the electrode; a cellulose-based resin film placed on a front side of the drug holding part or a complex film composed of a cation exchange membrane and a cellulose-based resin film placed on a front side of the cation exchange membrane, the complex film being placed on a front side of the drug holding part, in which the drug ions are administered through the cellulose-based resin film.04-22-2010

Mie Morita, Kusatsu-Shi JP

Patent application numberDescriptionPublished
20120070375COMPLEX AND CONTRAST AGENT FOR PHOTOIMAGING USING THE SAME - There is provided a gelatin-ICG complex that can suppress leakage of ICG included therein. The complex has a gelatin derivative including at least one of a phospholipid covalently bonded to a gelatin or a cholesterol covalently bonded to a gelatin, and indocyanine green.03-22-2012

Mie Sasaki, Tokyo JP

Patent application numberDescriptionPublished
20080286843Process for Preparing 2-Hydroxy-Substituted Pyridines - A process for preparing a 2-hydroxy-4-substituted pyridine compound using a microbiological method, a novel microorganism, and a novel compound are provided.11-20-2008
20110027864PROCESS FOR PREPARING 2-HYDROXY-4-SUBSTITUTED PYRIDINES - A process for preparing a 2-hydroxy-4-substituted pyridine compound using a microbiological method, a novel microorganism, and a novel compound are provided.02-03-2011
20110034697PROCESS FOR PREPARING 2-HYDROXY-4-SUBSTITUTED PYRIDINES - A process for preparing a 2-hydroxy-4-substituted pyridine compound using a microbiological method, a novel microorganism, and a novel compound are provided.02-10-2011